Advertisement

The Scientist

» clinical trials and developmental biology

Most Recent

image: Virus Versus Bacteria

Virus Versus Bacteria

By | April 17, 2013

A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.

1 Comment

image: Branching Out

Branching Out

By | April 1, 2013

Satellites of the Golgi apparatus generate the microtubules used to grow outer dendrite branches in Drosophila neurons.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

3 Comments

image: Pluripotent Until Needed

Pluripotent Until Needed

By | April 1, 2013

Microarrays help keep induced pluripotent stem cell lines in check, from start to finish.

0 Comments

image: Smurf-y Old Age

Smurf-y Old Age

By | April 1, 2013

Flies turning blue help researchers link the deterioration of the intestinal barrier to age-related death.

0 Comments

image: Clinical Trial Transparency in Europe?

Clinical Trial Transparency in Europe?

By | March 28, 2013

The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement